Publication:
Infective endocarditis on transcatheter aortic prosthesis: Are there differences with endocarditis on surgically implanted aortic bioprosthesis?

Loading...
Thumbnail Image

Date

2021-10-28

Authors

Fernandez-Aviles, Consuelo
Castillo, Juan C
Heredia, Gloria
Resua, Adriana
Gonzalez, Rafael
Pan, Manuel
Anguita, Manuel

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Wydawnictwo Via Medica
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Transcatheter aortic valve implantation (TAVI) has been a major advance in the treatment of aortic stenosis in elderly patients or those at very high surgical risk, and its indication has been extended to cases of high or even intermediate risk. For this reason, its use has increased notably in the past years [1]. One of the problems associated with TAVI is bioprosthesis infection [2]. The development of infective endocarditis (IE) on TAVI (IETAVI) is a serious complication, with the added problem that in many cases open-heart surgery is necessary to manage it.

Description

MeSH Terms

Aortic valve
Bioprosthesis
Humans
Prosthesis design
Prosthesis failure

DeCS Terms

Bioprótesis
Diseño de prótesis
Falla de prótesis
Válvula aórtica

CIE Terms

Keywords

Endocarditis, Endocarditis, bacterial, Heart valve prosthesis, Heart valve prosthesis implantation

Citation

Fernández-Avilés C, Castillo JC, Heredia G, Resúa A, González R, Pan M, et al. Infective endocarditis on transcatheter aortic prosthesis: Are there differences with endocarditis on surgically implanted aortic bioprosthesis? Cardiol J. 2022;29(3):511-513